Abstracts Archive - Page 2230 of 2607 - ACR Meeting Abstracts

Abstract Number: 54 • 2014 ACR/ARHP Annual Meeting
Concordance with the National Osteoporosis Foundation Treatment Guidelines After DXA Result Notification
Nicole Wright¹, Xin Lu², Stephanie Edmonds², Fredric Wolinsky², Douglas Roblin³, Peter Cram^4,5 and Kenneth G. Saag⁶, ¹Epidemiology, University of Alabama at Birmingham, Birmingham, AL, ²Public Health, University of Iowa, Iowa City, IA, ³Kaiser Permanente Georgia, Atlanta, GA, ⁴University of Iowa, Iowa City, IA, ⁵University of Toronto, Toronto, ON, Canada, ⁶Immunology & Rheumatology, The University of Alabama at Birmingham, Birmingham, AL
Background/Purpose: The National Osteoporosis Foundation (NOF) published treatment guidelines to help guide clinicians on which patients should be considered for osteoporosis (OP) therapy. We examined…
Abstract Number: 53 • 2014 ACR/ARHP Annual Meeting
Spine-Hip Diagnostic Discordance in the United Arab Emirates
Nicholas Wilson, Lidia Sanchez Riera, Iman Hobeldin, Salman Waheeduddin, Nehad Ibrahim, Suneetha Gonuguntla, Tahir Khan, Ritu Aneja, Samer Nuhaily and Mustafa Al Maini, Mafraq Hospital, Abu Dhabi, United Arab Emirates
Background/Purpose Diagnostic discordance for osteoporosis is the presence of different T-scores in two skeletal sites in the same subject leading to different WHO diagnostic categories. Discordance is defined…
Abstract Number: 51 • 2014 ACR/ARHP Annual Meeting
High Incidence of Non-Vertebral Osteoporotic Fracture and Hip Fracture in Brazilian Low-Income Community-Dwelling Elderly: A Population-Based Prospective Cohort Analysis from the São Paulo Ageing & Health (SPAH) Study
Diogo S. Domiciano¹, Luana G. Machado², Jaqueline B. Lopes², Camille P. Figueiredo², Valéria Caparbo², Liliam Takayama², Ricardo Oliveira³, Paulo R Menezes⁴ and Rosa M. R. Pereira⁵, ¹Rheumatology, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil, ²Rheumatology Division, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, ³RDO Diagnósticos Médicos, São Paulo, Brazil, ⁴Preventive Medicine, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil, ⁵Reumatologia, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil
Background/Purpose: There is considerable variability in the incidence of hip fracture among countries, even among different geographical areas within the same country. In Brazil, population…
Abstract Number: 52 • 2014 ACR/ARHP Annual Meeting
Visceral Fat Measured By Dual-Energy X-Ray Absorptiometry Is Associated with Increased Risk of Non-Spine Fractures in Nonobese Elderly Women: a Population-Based Prospective Cohort Analysis from the São Paulo Ageing & Health (SPAH) Study
Luana G. Machado¹, Diogo S Domiciano¹, Camille P. Figueiredo¹, Jaqueline B. Lopes¹, Valéria Caparbo¹, Liliam Takayama¹, Ricardo M. Oliveira² and Rosa M R Pereira¹, ¹Rheumatology Division, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, ²RDO Diagnosticos Medicos, São Paulo, Brazil
Background/Purpose The protective role of obesity on bone health has currently been questioned, since it has been demonstrated that visceral fat have a deleterious effect…
Abstract Number: 50 • 2014 ACR/ARHP Annual Meeting
Incidence and Risk Factors for Osteoporotic Vertebral Fracture in Low-Income Community-Dwelling Elderly: A Population-Based Prospective Cohort Study in Brazil. the São Paulo Ageing & Health (SPAH) Study
Diogo S. Domiciano¹, Luana G. Machado², Jaqueline B. Lopes², Valéria Caparbo², Liliam Takayama², Ricardo M. Oliveira³ and Rosa M. R. Pereira⁴, ¹Rheumatology, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil, ²Rheumatology Division, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil, ³RDO Diagnosticos Medicos, São Paulo, Brazil, ⁴Reumatologia, Faculdade de Medicina, University of São Paulo, São Paulo, Brazil
Background/Purpose: Vertebral fractures are associated with increased future fracture risk and mortality. No data on incidence of osteoporotic vertebral fracture have been reported in low-income…
Abstract Number: 49 • 2014 ACR/ARHP Annual Meeting
Long-Term Oral Bisphosphonate Use for Osteoporosis Among Older Women – US and Canadian Perspective
Nicole C. Wright¹, Wilson Smith², Amy H. Warriner³, Jeff Foster⁴, Ruth McConnell⁵, Huifeng Yun⁶, Mary H Melton⁷, Jeffrey R. Curtis⁴ and Kenneth G. Saag⁸, ¹Epidemiology, The University of Alabama at Birmingham, Birmingham, AL, ²Clinical Immunology/Rheumatology, University of Alabama at Birmingham, Birmingham, AL, ³Endocrinology, Diabetes, and Metabolism, The University of Alabama at Birmingham, Birmingham, AL, ⁴The University of Alabama at Birmingham, Birmingham, AL, ⁵University of Alabama at Birmingham, Birmingham, AL, ⁶Epidemiology, University of Alabama at Birmingham School of Public Health, Birmingham, AL, ⁷Medicine, The University of Alabama at Birmingham, Birmingham, AL, ⁸Immunology & Rheumatology, The University of Alabama at Birmingham, Birmingham, AL
Background/Purpose: Bisphosphonates (BPs) have been widely used for the treatment and prevention of osteoporosis for two decades. Although new parenteral preparations have been introduced, oral…
Abstract Number: 48 • 2014 ACR/ARHP Annual Meeting
Osteoporotic Women at High Risk for Fractures Despite Two Years of Oral Bisphosphonate Therapy: Analysis Using the Canadian Multicentre Osteoporosis Study
Jonathan D. Adachi¹, David Goltzman², Ankita Modi³, Jackson Tang⁴, Chun-Po S. Fan⁴ and Jessica Weaver³, ¹Division of Rheumatology, McMaster University, Hamilton, ON, Canada, ²McGill University, Montreal, QC, Canada, ³Global Health Outcomes, Merck & Co., Inc., Whitehouse Station, NJ, ⁴Asclepius Analytics, New York, NY
Background/Purpose Individuals with osteoporosis (OP) have an increased susceptibility to fractures. Prevention and treatment of postmenopausal OP is critical to decreasing the risk of non-traumatic…
Abstract Number: 47 • 2014 ACR/ARHP Annual Meeting
The Risk of Aplastic Anemia and Pancytopenia with Colchicine: A Retrospective Study of Integrated Health System Database
Jasvinder A. Singh¹, Shuo Yang² and Jeff Foster³, ¹University of Alabama at Birmingham, Birmingham, AL, ²Clinical Immunology/Rheumatology, University of Alabama at Birmingham, Birmingham, AL, ³The University of Alabama at Birmingham, Birmingham, AL
Background/Purpose Colchicine is a commonly used medication, sometime associated with bone marrow toxicity. The objective of this study was to examine the risk of severe…
Abstract Number: 46 • 2014 ACR/ARHP Annual Meeting
Xanthine Oxidase Inhibitors and Risk of Type 2 Diabetes in Patients with Gout
Seoyoung C. Kim¹, John D. Seeger², Jun Liu³ and Daniel H. Solomon⁴, ¹Div. of Pharmacoepidemiology and Pharmacoeconomics, Div. of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, ²Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital/Harvard Medical School, Boston, MA, ³Division of Pharmaoepidemiology, Brigham and Women's Hospital, Boston, MA, ⁴Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA
Background/Purpose: Hyperuricemia and gout are associated with an increased risk of type 2 diabetes (T2D). Xanthine oxidase inhibitors (XOI), allopurinol and febuxostat, are the main…
Abstract Number: 44 • 2014 ACR/ARHP Annual Meeting
Physical Function, Hyperuricemia and Gout in Older Adults
Mara McAdams-DeMarco¹, Bridget Burke², Andrew Law³, Anna Kottgen⁴, Alan N. Baer⁵ and Josef Coresh¹, ¹Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, ²Johns Hopkins University, Baltimore, MD, ³Epidemiology, Johns Hopkins, Baltimore, MD, ⁴Renal Division, University Hospital Freiburg, Freiburg, Germany, ⁵Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD
Background/Purpose: The prevalence of gout is higher in older adults than in younger adults and these patients are at risk of physical disability. We sought…
Abstract Number: 43 • 2014 ACR/ARHP Annual Meeting
Deaths Associated with Ankylosing Spondylitis in France from 1969 to 2009
Clement Prati¹, Daniel Wendling² and Xavier Guillot³, ¹Rhumatologie, Hopital Jean Minjoz, Besancon, France, ²Service de Rhumatologie, CHU J Minjoz, Besancon, France, ³rheumatology, Besançon, France
Background/Purpose Ankylosing spondylitis (AS) is a chronic inflammatory joint disease that can lead to chronic pain in the axial and peripheral joints and to functional…
Abstract Number: 42 • 2014 ACR/ARHP Annual Meeting
The Prevalence of Ankylosing Spondylitis in Sweden – a Nationwide Register Study
Sofia Exarchou¹, Ulf Lindström², Johan Askling³, Jonas Eriksson⁴, Helena Forsblad-d'Elia², Lars Erik Kristensen⁵, Martin Neovius⁴, Carl Turesson¹ and Lennart T. Jacobsson², ¹Section of Rheumatology, Department of Clinical Sciences, Malmö, Lund University, Malmö, Sweden, ²Department of Rheumatology and Inflammation Research, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden, ³Clinical Epidemiology Unit, Rheumatology Unit, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden, ⁴Clinical Epidemiology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden, ⁵Section of Rheumatology, Department of Clinical Sciences, Lund University, Malmö, Sweden
Background/Purpose: Reported Ankylosing Spondylitis (AS) prevalence estimates vary considerably, and there is a lack of nationwide estimates. Previous studies by our group support the validity…
Abstract Number: 41 • 2014 ACR/ARHP Annual Meeting
The Impact of Ankylosing Spondylitis on Work Impairment: Data from the Scotland Registry for Ankylosing Spondylitis
Linda E. Dean¹, Alan G. MacDonald², Roger D. Sturrock³, John Hunter⁴, David Marshall⁵, Gary J. Macfarlane¹ and Gareth T. Jones¹, ¹Musculoskeletal Research Collaboration (Epidemiology Group), University of Aberdeen, Aberdeen, United Kingdom, ²Department of Rheumatology, Aberdeen Royal Infirmary, Aberdeen, United Kingdom, ³Centre for Rheumatic Diseases, Glasgow Royal Infirmary, Glasgow, United Kingdom, ⁴Department of Rheumatology, Gartnavel General Hospital, Glasgow, United Kingdom, ⁵Department of Rheumatology, Inverclyde Royal Hospital, Greenock, United Kingdom
Background/Purpose: The impact of ankylosing spondylitis (AS) on work status is substantial. While the majority of studies focus on the prevalence of absenteeism in this…
Abstract Number: 45 • 2014 ACR/ARHP Annual Meeting
Body Mass Index Across the Lifespan and Lifetime Incidence of Gout in Men
Allan C. Gelber¹, Lucy Meoni², Michael Klag² and Joseph Gallo², ¹Medicine/ Rheumatology, Johns Hopkins University, Baltimore, MD, ²Medicine, Johns Hopkins University, Baltimore, MD
Background/Purpose: Gout is the leading cause of inflammatory arthritis in men and is linked to higher levels of body weight and obesity in mid-adult life.…
Abstract Number: 22 • 2014 ACR/ARHP Annual Meeting
Adenosine a_2A Receptor (A2AR) Stimulation Inhibits Osteoclast Differentiation and Promotes Osteoblast Formation By Regulation of Axon Guidance Proteins
Aranzazu Mediero¹, Miguel Perez-Aso² and Bruce N. Cronstein³, ¹Medicine, Division of Translational Medicine, NYU School of Medicine, New York, NY, ²545 1st Ave., New York University, New York City, NY, ³NYU School of Medicine, Division of Rheumatology, New York, NY
Background/Purpose Semaphorins (Sema), axonal guidance proteins, play a role in communication between osteoclast and osteoblast. Thus, sema4D, secreted by osteoclasts, binds to its receptor PlexinB1…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].